Biblio

Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
Journal Article
Daoutsali, E., Buijsen, R.A.M., van de Pas, S., Jong, A.'t, Mikkers, H., Brands, T., Eussen, B., de Klein, A., van der Graaf, L.M., Pepers, B.A., et al. (2018). Stem Cell Res34, 101359.
Daoutsali, E., Buijsen, R.A.M., van de Pas, S., Jong, A.'t, Mikkers, H., Brands, T., Eussen, B., de Klein, A., van der Graaf, L.M., Pepers, B.A., et al. (2018). Stem Cell Res34, 101359.
Guidoni, L., Ricci-Vitiani, L., Rosi, A., Palma, A., Grande, S., Luciani, A.Maria, Pelacchi, F., di Martino, S., Colosimo, C., Biffoni, M., et al. (2013). (1) H NMR detects different metabolic profiles in glioblastoma stem-like cells.Nmr Biomed.
Rosi, A., Ricci-Vitiani, L., Biffoni, M., Grande, S., Luciani, A.Maria, Palma, A., Runci, D., Cappellari, M., De Maria, R., Guidoni, L., et al. (2015). (1) H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness.Nmr Biomed.
Kusuyama, J., Seong, C.Hwan, Ohnishi, T., Bandow, K., and Matsuguchi, T. (2016). 10. Low-Intensity Pulsed Ultrasound (LIPUS) Stimulation Helps to Maintain the Differentiation Potency of Mesenchymal Stem Cells by Induction in Nanog Protein Transcript Levels and Phosphorylation.J Orthop Trauma30, S4-S5.
Sidana, S., M Sidiqi, H., Dispenzieri, A., Buadi, F.K., Lacy, M.Q., Muchtar, E., Dingli, D., Hayman, S.R., Gonsalves, W.I., Kapoor, P., et al. (2019). 15 Year Overall Survival Rates after Autologous Stem Cell Transplantation for AL Amyloidosis.Am J Hematol.
Schiro, A., Wilkinson, F., Weston, R., Smyth, J.V., Boulton, A.J., Serracino-Inglott, F., and Alexander, Y.M. (2014). 179 The Role Of Microparticles in Carotid Disease.Heart100, A101.
Bai, F., Wang, L., Li, Z., Yi, L., Zuo, Z., Zhang, C., Shan, Y., Yang, C., Peng, R., Yang, R., et al. (2018). 17α-Ethinyl-androst-5-ene-3β, 17β-diol, a novel potent oral radioprotective agent, confers radioprotection of hematopoietic stem and progenitor cells in a granulocyte colony stimulating factor-independent manner.Int J Radiat Oncol Biol Phys.
Ismail, S., O'Brien, T., and Barry, F. (2014). 188 The Cardioprotective Effect of MSC Secreted Protein in an in Vitro Model of Myocardial Injury: the Mechanistic Insight.Heart100, A105.
Müller, J., Greiner, J.Fw, Zeuner, M., Brotzmann, V., Schäfermann, J., Wieters, F., Widera, D., Sudhoff, H., Kaltschmidt, B., and Kaltschmidt, C. (2016). 1,8-cineole potentiates IRF3-mediated antiviral response in human stem cells and an ex vivo model of rhinosinusitis.Clin Sci (Lond).
Kim, W., Le, T.M., Wei, L., Poddar, S., Bazzy, J., Wang, X., Uong, N.T., Abt, E.R., Capri, J.R., Austin, W.R., et al. (2016). [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.Proc Natl Acad Sci U S A.
Agostini, F., Ruzza, M., Corpillo, D., Biondi, L., Acquadro, E., Canepa, B., Viale, A., Battiston, M., Serra, F., Aime, S., et al. (2018). 1H-NMR and MALDI-TOF MS as metabolomic quality control tests to classify platelet derived medium additives for GMP compliant cell expansion procedures.Plos One13, e0203048.
Agostini, F., Ruzza, M., Corpillo, D., Biondi, L., Acquadro, E., Canepa, B., Viale, A., Battiston, M., Serra, F., Aime, S., et al. (2018). 1H-NMR and MALDI-TOF MS as metabolomic quality control tests to classify platelet derived medium additives for GMP compliant cell expansion procedures.Plos One13, e0203048.
Ludwig, T.E., Kujak, A., Rauti, A., Andrzejewski, S., Langbehn, S., Mayfield, J., Fuller, J., Yashiro, Y., Hara, Y., and Bhattacharyya, A. (2018). 20 Years of Human Pluripotent Stem Cell Research: It All Started with Five Lines.Cell Stem Cell23, 644-648.
Guan, L., Suggs, A., Ahsanuddin, S., Tarrillion, M., Selph, J., Lam, M., and Baron, E. (2016). 2016 Arte Poster Competition First Place Winner: Circadian Rhythm and UV-Induced Skin Damage: An In Vivo Study.J Drugs Dermatol15, 1124-1130.
Zhao, J., Bolton, E., Randle, L., J Bradley, A., and Lever, A. (2014). 206 Prospects for Utilisation of Late Outgrowth Endothelial Progenitor Cells as Therapy to Prevent Transplant Vasculopathy.Heart100, A113.
Zhao, J., Bolton, E., Randle, L., J Bradley, A., and Lever, A. (2014). 206 Prospects for Utilisation of Late Outgrowth Endothelial Progenitor Cells as Therapy to Prevent Transplant Vasculopathy.Heart100, A113.
Chérel, M., Gouard, S., Gaschet, J., Saï-Maurel, C., Bruchertseifer, F., Morgenstern, A., Bourgeois, M., Gestin, J.-F., Bodéré, F.Kraeber, Barbet, J., et al. (2013). 213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma.J Nucl Med54, 1597-604.
Chérel, M., Gouard, S., Gaschet, J., Saï-Maurel, C., Bruchertseifer, F., Morgenstern, A., Bourgeois, M., Gestin, J.-F., Bodéré, F.Kraeber, Barbet, J., et al. (2013). 213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma.J Nucl Med54, 1597-604.
Chérel, M., Gouard, S., Gaschet, J., Saï-Maurel, C., Bruchertseifer, F., Morgenstern, A., Bourgeois, M., Gestin, J.-F., Bodéré, F.Kraeber, Barbet, J., et al. (2013). 213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma.J Nucl Med54, 1597-604.
Chérel, M., Gouard, S., Gaschet, J., Saï-Maurel, C., Bruchertseifer, F., Morgenstern, A., Bourgeois, M., Gestin, J.-F., Bodéré, F.Kraeber, Barbet, J., et al. (2013). 213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma.J Nucl Med54, 1597-604.
Brindley, D.A., Arshad, Z., Luo, D., Dopson, S., Hollander, G., Frost, S., Bountra, C., and Smith, J.A. (2015). 21(st) Century Cures Act: An Act of Cure or Diagnosis?.Rejuvenation Res18, 295-298.
Brindley, D.A., Arshad, Z., Luo, D., Dopson, S., Hollander, G., Frost, S., Bountra, C., and Smith, J.A. (2015). 21(st) Century Cures Act: An Act of Cure or Diagnosis?.Rejuvenation Res18, 295-298.
Tartibi, H.M., Hershfield, M.S., and Bahna, S.L. (2015). A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.Pediatrics.
Hanauer, N., Latreille, P.Luc, Alsharif, S., and Banquy, X. (2015). 2D, 3D and 4D Active Compound Delivery in Tissue Engineering and Regenerative Medicine.Curr Pharm Des.

Pages